LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Phillip B. Donenberg, its CFO, will present an overview of the company and its recently completed acquisition of Cell Genesys, as well as give a LibiGel® (testosterone gel) update at the Lazard Capital Markets 6th Annual Healthcare Conference today, Tuesday November 17, 2009 at the St. Regis Hotel in New York City. Mr. Donenberg will present at 11:25 am local time.
